S M Weenink - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

S M Weenink

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Immunology and Cell Biology|February 1, 1997

Antigen presentation by MHC class II moleculesS M Weenink, A M Gautam

International Immunology|February 1, 1997

A continuous central motif of invariant chain peptides, CLIP, is essential for binding to various I-A MHC class II moleculesS M Weenink, P J Milburn, A M Gautam

Veterinary Immunology and Immunopathology|August 19, 2008

Autoantibodies to GAD65 and IA-2 in canine diabetes mellitusL J Davison, S M Weenink, M R Christie, et al.

Journal of Autoimmunity|May 19, 2009

Autoantibodies and associated T-cell responses to determinants within the 831-860 region of the autoantigen IA-2 in Type 1 diabetesS M Weenink, J Lo, C R Stephenson, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Immunology and Cell Biology|February 1, 1997

Antigen presentation by MHC class II moleculesS M Weenink, A M Gautam

International Immunology|February 1, 1997

A continuous central motif of invariant chain peptides, CLIP, is essential for binding to various I-A MHC class II moleculesS M Weenink, P J Milburn, A M Gautam

Veterinary Immunology and Immunopathology|August 19, 2008

Autoantibodies to GAD65 and IA-2 in canine diabetes mellitusL J Davison, S M Weenink, M R Christie, et al.

Journal of Autoimmunity|May 19, 2009

Autoantibodies and associated T-cell responses to determinants within the 831-860 region of the autoantigen IA-2 in Type 1 diabetesS M Weenink, J Lo, C R Stephenson, et al.

Pageof 1